iRhythm Closes $287.5M VitalConnect Acquisition, Final Terms Disclosed
IRTC is trading near its 52-week low of $100.846 (9.4% above the low).
Summary
iRhythm completed its $287.5M acquisition of VitalConnect, disclosing final consideration of $237.5M cash plus up to 423,334 shares and $10M in working capital funding. The deal expands its cardiac monitoring platform and is expected to boost revenue growth in 2027.
Key Events · M&A and Partnerships · IRTC
-
VitalConnect Acquisition Completed
The acquisition of VitalConnect closed on October 5, 2026, expanding iRhythm's cardiac monitoring platform into mobile cardiac telemetry and multi-vitals monitoring.
-
Final Consideration Disclosed
Purchase price consisted of $237.5 million in cash (subject to adjustments), up to 423,334 shares issued at closing, and $10.0 million in working capital funding provided between signing and closing.
-
Strategic Expansion
The deal broadens iRhythm's addressable market across ambulatory, inpatient, remote, and hospital-to-home care settings, with VitalConnect's platform capable of monitoring up to 11 physiological parameters.
-
Financial Guidance Update
Updated 2026 financial guidance inclusive of VitalConnect will be provided during the third quarter earnings call on November 5, 2026.
Analysis · IRTC · Industrial Applications And Services
The acquisition of VitalConnect has been completed, finalizing terms that were previously announced but not fully quantified. The deal closed with $237.5 million in cash, up to 423,334 shares issued, and an additional $10 million in working capital funding. This expands iRhythm's cardiac monitoring platform into mobile cardiac telemetry and multi-vitals monitoring, broadening its addressable market across ambulatory, inpatient, and hospital-to-home care. Management expects the deal to enhance revenue growth beginning in 2027 while preserving its 15% adjusted EBITDA margin target. Updated 2026 guidance will be provided on the November 5 earnings call.
How filings like this one have moved
In the 30 days to Oct 5, 2026, 29.2% of the 1496 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.63%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, IRTC was trading at $110.37 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $3.6B. The 52-week trading range was $100.85 to $212.00. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.